Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Br J Anaesth ; 130(6): 647-650, 2023 06.
Artículo en Inglés | MEDLINE | ID: mdl-36967280

RESUMEN

A randomised trial published in the British Journal of Anaesthesia describes hypnosis compared with general anaesthesia in 60 children undergoing superficial surgery. We describe a definition of clinical hypnosis; the goals and conduct of hypnotic communication; and its potential as both an adjunct and, in suitable cases, alternative to traditional pharmacological anaesthesia.


Asunto(s)
Hipnosis , Niño , Humanos , Anestesia General , Atención Perioperativa
2.
Gut ; 56(10): 1439-44, 2007 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17356040

RESUMEN

BACKGROUND: Based on equivocal clinical data, intravenous antioxidant therapy has been used for the treatment of severe acute pancreatitis. To date there is no randomised comparison of this therapy in severe acute pancreatitis. METHODS: We conducted a randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in patients with predicted severe acute pancreatitis. Forty-three patients were enrolled from three hospitals in the Manchester (UK) area over the period June 2001 to November 2004. Randomisation stratified for APACHE-II score and hospital site, and delivered groups that were similar at baseline. RESULTS: Relative serum levels of antioxidants rose while markers of oxidative stress fell in the active treatment group during the course of the trial. However, at 7 days, there was no statistically significant difference in the primary end point, organ dysfunction (antioxidant vs placebo: 32% vs 17%, p = 0.33) or any secondary end point of organ dysfunction or patient outcome. CONCLUSIONS: This study provides no evidence to justify continued use of n-acetylcysteine, selenium, vitamin C based antioxidant therapy in severe acute pancreatitis. In the context of any future trial design, careful consideration must be given to the risks raised by the greater trend towards adverse outcome in patients in the treatment arm of this study.


Asunto(s)
Antioxidantes/uso terapéutico , Pancreatitis/tratamiento farmacológico , APACHE , Acetilcisteína/efectos adversos , Acetilcisteína/sangre , Acetilcisteína/uso terapéutico , Enfermedad Aguda , Adulto , Anciano , Antioxidantes/efectos adversos , Antioxidantes/farmacocinética , Ácido Ascórbico/efectos adversos , Ácido Ascórbico/sangre , Ácido Ascórbico/uso terapéutico , Método Doble Ciego , Esquema de Medicación , Quimioterapia Combinada , Femenino , Humanos , Infusiones Intravenosas , Masculino , Persona de Mediana Edad , Estrés Oxidativo/efectos de los fármacos , Pancreatitis/sangre , Selenio/efectos adversos , Selenio/sangre , Selenio/uso terapéutico , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA